A STUDY TO EVALUATE THE EFFICACY OF CJH1 (CLR4001) IN PARKINSON'S DISEASE

Alexandra Marine and General Hospital

Status and phase: Unknown; Phase 2; Phase 1

Conditions: Parkinson's Disease

Treatments: Drug: CJH1 (CLR4001)

Study type: Interventional

Funder types: Other

Identifiers

NCT01684475

CJH1 Trial

Details and patient eligibility

About

The purpose of this study is to assess the ability of CJH1 to increase the sensitivity of dopamine receptors and thereby reduce symptoms of Parkinson's Disease.

Enrollment: 21 estimated patients

Sex: All

Ages: 40 to 85 years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Patient's with Parkinson's disease

Exclusion criteria

• Contraindications to study medication

Trial design

Primary purpose: Treatment

Allocation: N/A

Interventional model: Single Group Assignment

Masking: Double Blind

---

21 participants in 1 patient group

Treatment with CJH1

Experimental group

Treatment:

Drug: CJH1 (CLR4001)